XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Beginning balance (in shares) at Dec. 31, 2020 55,497,133        
Beginning balance at Dec. 31, 2020 $ 55,497 $ 263,629,116 $ (267,258) $ (148,542,194) $ 114,875,161
Net loss       (4,158,891) (4,158,891)
Other comprehensive income (loss)     80,039   80,039
Issuance of common stock, net of expenses (in shares) 14,950,000        
Issuance of common stock, net of expenses $ 14,950 119,105,487     119,120,437
Cashless exercise of options for common stock (in shares) 4,354        
Cashless exercise of options for common stock $ 4 (4)      
Exercise of warrants for common stock (in shares) 491,133        
Exercise of warrants for common stock $ 491 1,595,691     1,596,182
Share based compensation (in shares) 40,525        
Share based compensation $ 41 129,674     129,715
Ending balance (in shares) at Mar. 31, 2021 70,983,145        
Ending balance at Mar. 31, 2021 $ 70,983 384,459,964 (187,219) (152,701,085) 231,642,643
Beginning balance (in shares) at Dec. 31, 2021 71,025,738        
Beginning balance at Dec. 31, 2021 $ 71,026 384,852,107 (255,588) (170,864,782) 213,802,763
Net loss       (5,111,726) (5,111,726)
Other comprehensive income (loss)     (31,160)   (31,160)
Share based compensation (in shares) 83,963        
Share based compensation $ 84 211,244     211,328
Ending balance (in shares) at Mar. 31, 2022 71,109,701        
Ending balance at Mar. 31, 2022 $ 71,110 $ 385,063,351 $ (286,748) $ (175,976,508) $ 208,871,205